#obesity-treatment-stocks
#obesity-treatment-stocks

Alternative medicine

Understanding and Navigating Weight Loss Medications

Healthcare

What Eli Lilly's new employer platform could mean for access to weight-loss drugs

Medicine

What happens after Ozempic shocked researchers

The Psychology of Ozempic

GLP-1 drugs reduce appetite and desire but may dampen all desires including healthy ones, potentially creating depression-like symptoms and reducing motivation for work, relationships, and life satisfaction.

Experts warn that GLP-1s are leading to the resurgence of a 17thcentury disease

GLP-1 drugs suppress appetite without ensuring proper nutrition, causing severe vitamin deficiencies and diseases like scurvy in users.

48 minutes ago

US news

Quit a GLP-1? Plan to start again? It's not recommended, but plenty of people do it

Understanding and Navigating Weight Loss Medications

GLP-1 and semaglutide medications effectively reduce obesity but require medical guidance and are not standalone solutions to weight management.

Healthcare

What Eli Lilly's new employer platform could mean for access to weight-loss drugs

What happens after Ozempic shocked researchers

Stopping GLP-1 medications like Ozempic does not typically lead to significant weight regain, as many patients switch treatments or restart therapy.

The Psychology of Ozempic

Experts warn that GLP-1s are leading to the resurgence of a 17thcentury disease

GLP-1 drugs suppress appetite without ensuring proper nutrition, causing severe vitamin deficiencies and diseases like scurvy in users.

more#glp-1-medications

Men and women with obesity face very different hidden health risks

Obesity affects men and women differently, impacting heart health, metabolism, and inflammation, necessitating personalized treatment strategies.

Early weight gain is linked to lifelong health consequences

Gaining weight at a young age significantly increases the risk of early death and long-term health issues.

fromWIRED

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.

Medicine

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

Men and women with obesity face very different hidden health risks

Obesity affects men and women differently, impacting heart health, metabolism, and inflammation, necessitating personalized treatment strategies.

Early weight gain is linked to lifelong health consequences

Gaining weight at a young age significantly increases the risk of early death and long-term health issues.

fromWIRED

FDA Approves Eli Lilly's GLP-1 Pill

The FDA approved Foundayo, a new daily obesity pill by Eli Lilly, expanding options for weight loss treatments alongside injectable GLP-1 medications.

fromwww.independent.co.uk

Medicine

GLP-1 drugs don't work for everyone. But personalized obesity care in the future might

more#obesity

UK politics

10 hours ago

Calories on menus are helpful for those with binge eating disorders

Calorie labels on menus may aid recovery for people with binge eating disorders despite mixed views on their impact among those with eating disorders.

fromenglish.elpais.com

17 hours ago

Berberine: Benefits and myths of the so-called natural Ozempic'

Berberine shows metabolic benefits but is not a substitute for Ozempic and should be used cautiously.

Almost 2bn to be affected by metabolic liver disease by 2050, study suggests

The global prevalence of metabolic dysfunction-associated steatotic liver disease (MASLD) has surged to 1.3 billion people, marking a 143% increase over the past three decades. By 2050, projections indicate that this number could rise to 1.8 billion, primarily due to rising obesity and blood sugar levels.

Medicine

#glp-1

Exercise

The GLP-1 gold rush is creating winners far beyond pharma

GLP-1 users are significantly increasing spending across various sectors due to associated costs and lifestyle changes.

22 hours ago

What a dietitian would eat in a day on GLP-1s to get enough protein, fiber, and nutrients

GLP-1 medications reduce appetite but do not lessen the need for essential nutrients, necessitating nutrient-dense meals.

fromThe Atlantic

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.

Marketing

Ro CEO on the next phase of the Ozempic boom

Medicine

A new weight loss pill is here and it could reshape the GLP-1 market

Public health

Five ways weight-loss jabs are changing spending habits

Exercise

The GLP-1 gold rush is creating winners far beyond pharma

GLP-1 users are significantly increasing spending across various sectors due to associated costs and lifestyle changes.

22 hours ago

What a dietitian would eat in a day on GLP-1s to get enough protein, fiber, and nutrients

GLP-1 medications reduce appetite but do not lessen the need for essential nutrients, necessitating nutrient-dense meals.

fromThe Atlantic

A Shot to Lose Weight, Then a Pill to Keep It Off

New GLP-1 pills are less effective than injections but offer convenience for long-term weight management.

Marketing

Ro CEO on the next phase of the Ozempic boom

Medicine

A new weight loss pill is here and it could reshape the GLP-1 market

Public health

Five ways weight-loss jabs are changing spending habits

more#glp-1

fromFortune

Why this Gilead Sciences exec says managing energy, not time, drives performance | Fortune

"I think about it like a piggy bank. Some meetings, tasks, and decisions draw heavily from it, particularly long discussions that go in circles..."

Women in technology

#glp-1-drugs

fromInsideHook

Silicon Valley food

How Are GLP-1 Drugs Reshaping the Hot Sauce Market?

fromwww.independent.co.uk

Exercise

Strength persists after a mid-life course of obesity drugs

Media industry

How weight-loss jabs are changing the way we spend money

Mental health

Weight-loss drugs do nothing to address the troubled relationships we have with our bodies | Susie Orbach

Public health

Are obesity drugs causing a severe complication? What the science says

Medicine

The GLP-1 saga is only getting juicier and messier

Silicon Valley food

fromInsideHook

How Are GLP-1 Drugs Reshaping the Hot Sauce Market?

GLP-1 drugs are influencing food trends, leading to increased sales for hot sauce manufacturers like Tapatío due to consumer demand for bold flavors.

fromwww.independent.co.uk

Exercise

Strength persists after a mid-life course of obesity drugs

Media industry

How weight-loss jabs are changing the way we spend money

Mental health

Weight-loss drugs do nothing to address the troubled relationships we have with our bodies | Susie Orbach

Public health

Are obesity drugs causing a severe complication? What the science says

The GLP-1 saga is only getting juicier and messier

The FDA warned Novo Nordisk about failing to disclose risks and report deaths linked to semaglutide, while GLP-1 drugs surge in popularity for diabetes and weight loss despite unapproved market alternatives.

Social media marketing

Influencers May Share Misleading Information About Prescriptions

Social media influencers promoting prescription drugs often share misleading information, complicating audience recognition of promotional intent.

fromAol

Social media marketing

Prescription Drug Content On Social Media Often Misleading, Study Finds

Social media influencers often spread misinformation about prescription drugs, complicating audience recognition of promotional intent and highlighting the need for updated regulations.

Social media marketing

fromHealthline

Influencers May Share Misleading Information About Prescriptions

Social media influencers promoting prescription drugs often share misleading information, complicating audience recognition of promotional intent.

Social media marketing

fromAol

Prescription Drug Content On Social Media Often Misleading, Study Finds

Social media influencers often spread misinformation about prescription drugs, complicating audience recognition of promotional intent and highlighting the need for updated regulations.

Why Some 'Healthy' Snacks Might Leave You Hungrier - Tasting Table

Healthy snacks often leave people hungry due to low caloric content and lack of macronutrients.

Gen Z wants their job to cover GLP-1 weight-loss drugs, survey suggests

A new ZipHealth survey of over 1,000 workers found that nearly half (47%) of Gen Z said GLP-1 coverage would affect their choices between two similar jobs.

Healthcare

Wearables

fromThe Verge

A year of continuous glucose monitoring pushed me to the edge

Glucose tracking is increasingly popular among non-diabetics, with many using continuous glucose monitors for health insights.

#weight-loss

Medicine

Stanford scientists discover "natural Ozempic" without side effects

Psychology

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.

Medicine

New light shed on who benefits most from weight-loss jabs

fromIndependent

5 days ago

Medicine

Protein deficiencies found in users of weight-loss jabs, new research shows

How well GLP-1 weight loss drugs work may depend on your genetics

Genetic variations can explain why some individuals do not respond to weight-loss drugs like Wegovy and Zepbound.

fromABC7 New York

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.

Stanford scientists discover "natural Ozempic" without side effects

A newly discovered molecule, BRP, reduces appetite and promotes fat loss without the side effects of Ozempic.

Psychology

What Weight-Loss Drugs Reveal About How We Judge Effort

Visible struggle in weight loss is often misinterpreted as greater effort, while underlying biological and psychological factors play a significant role.

New light shed on who benefits most from weight-loss jabs

Genetic variations in appetite and digestion can enhance weight loss effectiveness of drugs like Wegovy and Mounjaro.

fromIndependent

5 days ago

Medicine

Protein deficiencies found in users of weight-loss jabs, new research shows

How well GLP-1 weight loss drugs work may depend on your genetics

Genetic variations can explain why some individuals do not respond to weight-loss drugs like Wegovy and Zepbound.

fromABC7 New York

FDA grants speedy approval to Eli Lilly's weight-loss pill for obesity

Eli Lilly's orforglipron, branded as Foundayo, is a new FDA-approved weight-loss pill expected to be available soon.

more#weight-loss

Wave Life Sciences Slips as Obesity Data Fails to Convince

The INLIGHT interim readout reported a 14.3% placebo-adjusted reduction in visceral fat six months after a single dose, alongside preservation of lean muscle mass - a differentiated profile compared to GLP-1 therapies that often reduce muscle alongside fat.

Cancer

The FDA approves a new obesity pill, giving patients another option

We've created a small molecule chemical which gets in your body very well. It can mimic the effects of the peptide and can be taken more conveniently any time of day without any food or water restrictions.

US news

Eli Lilly vs. Novo Nordisk: The Obesity Drug Race Has a New Leader

Lilly's fourth quarter revenue reached $19.29 billion, up 42.6% year-over-year, powered almost entirely by two products. Mounjaro generated $7.41 billion, up 110%, while Zepbound added $4.26 billion, up 123%.

Medicine

Exercise

Just a few minutes of effort could lower your risk of 8 major diseases

Just a few minutes of vigorous activity daily can significantly reduce the risk of major diseases like heart disease and dementia.

Who Benefits From Amazon Pharmacy Stocking Eli Lilly's New Weight Loss Pill

Amazon Pharmacy's decision to stock Foundayo at One Medical kiosks represents a significant shift in how Americans can access weight-loss medications, with plans for same-day home delivery.

Medicine

Why obesity drugs work better for some people: these genes hold clues

Genetic variants influence individual responses to obesity drugs, affecting weight loss and side effects.

Genetics may help explain why results from weight-loss jabs vary, say scientists

Genetic variations in gut hormone pathways may explain differing responses to weight-loss medications like GLP1 receptor agonists.

Why obesity drugs work better for some people: these genes hold clues

Genetic variants influence individual responses to obesity drugs, affecting weight loss and side effects.

Genetics may help explain why results from weight-loss jabs vary, say scientists

Genetic variations in gut hormone pathways may explain differing responses to weight-loss medications like GLP1 receptor agonists.

more#genetics

The weight-loss drug rivalry heats up as another GLP-1 pill gains FDA approval

Eli Lilly's orforglipron received FDA approval as a weight loss treatment, showing significant weight loss in clinical trials.

Miscellaneous

fromBoston.com

Massachusetts joins insurers cutting coverage for popular weight-loss drugs

Massachusetts ended GLP-1 weight loss drug coverage for 460,000 state employees in a 10-7 vote to reduce $46 million in annual costs and control state budget strain.

Weight-loss jabs will be offered on NHS for people at risk of further heart attacks

Wegovy will be provided for free on the NHS to over a million at-risk individuals in England to reduce heart attack and stroke risks.

Startup companies

fromBoston.com

Two Boston startups join the race to create the next major weight-loss drug

Boston startups Vivtex and Nimbus Therapeutics partner with major pharmaceutical companies to develop next-generation oral obesity treatments using advanced drug delivery and AI technologies.

Public health

fromBBC

Inside Health - What are the side effects of weight loss drugs? - BBC Sounds

Weight loss drugs were used by over 1.5 million UK adults in 2024–25 and can cause side effects including nausea and painful gallstones.

Business

VanEck Pharmaceutical Fund Bets Big on Weight-Loss Drug Market Approaching $150 Billion

Concentrated exposure to GLP-1 leaders drove PPH's gains, but rising competition, pricing pressure, and concentration risk threaten future performance.

Public health

Could weight-loss jabs be behind rising gallbladder removals?

Specialist doctors call for more research into a possible link between GLP-1 weight-loss injections and rising gallbladder removals and gallstones.

These cells in the body remember fat. Here's what that means for weight loss

Fat cells and immune cells retain epigenetic memory of obesity, making weight regain easier even after significant weight loss through any method.

Healthcare

fromThe Atlantic

GLP-1 Envy Was Just the Beginning

Telehealth companies market paid services that promise wealthy-style, personalized concierge care, highlighting and monetizing the divide between elite proactive care and reactive mainstream care.

#glp-1-receptor-agonists

4 weeks ago

Can weight-loss pills replace injectables? What the science says

Oral anti-obesity pills based on GLP-1 receptor agonists are entering the market, offering needle-free alternatives to injectable weight-loss drugs, though they produce less weight loss than injections.

Medicine

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

4 weeks ago

Can weight-loss pills replace injectables? What the science says

more#glp-1-receptor-agonists

Medicine

Weight loss drugs may stop people getting addicted to drugs and alcohol, study finds

Molecule in python blood could pave way for new obesity drugs, scientists say

Scientists identified a python metabolite called pTOS that triggers satiety and weight loss in obese mice, potentially leading to new obesity treatments similar to Wegovy.

Healthcare

fromBusiness Matters

Employers rethink healthcare benefits as weight-loss drugs reshape workplace provision

Employers must redesign workplace healthcare as rising employee demand for GLP-1 weight-management drugs increases costs and pressures benefit plans.

#glp-1-agonists

Medicine

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Medicine

The overlooked nutrition risk of Ozempic and Wegovy

The Guardian view on weight-loss jabs and addiction: there is too much moralising about these remarkable medicines | Editorial

Weight-loss drugs show promise in reducing addiction risk, suggesting they may address shared biological mechanisms between food and drug cravings in the brain.

Medicine

The overlooked nutrition risk of Ozempic and Wegovy

more#glp-1-agonists

Healthcare

Wegovy and Ozempic maker forecasts sharp drop in revenue for 2026

Novo Nordisk forecasts 5–13% revenue decline this year due to US price cuts, rising competition, and semaglutide patent expiries despite Wegovy pill uptake.

fromFortune

Hims & Hers scraps copycat Wegovy weight-loss pill after probe | Fortune

After having "constructive conversations with stakeholders," Hims decided to stop offering the treatment, the company said in a post on X Saturday.

Health

An endocrinologist tried a new weight loss approach and it worked

A Colorado endocrinologist helped spark a quiet revolution in weight care by changing how primary care clinics talk about - and treat - obesity. Instead of vague advice to "eat less and exercise more," a new system called PATHWEIGH gave patients a clear, judgment-free path to real medical support for weight management.

Medicine

fromIndependent

Are people spending less on food when they take weight-loss drugs?

Some individuals who can afford costly weight-loss medications may reduce household grocery spending significantly, offsetting part of the medication cost.